Belite Bio (BLTE) EBITDA (2022 - 2026)
Belite Bio (BLTE) posted quarterly EBITDA of -$32.7 million for Q1 2026, up 100.0% year-over-year from -$16.3 million in Q1 2025, and down 116308.45% quarter-over-quarter from -$28077.0 in Q4 2025.
Belite Bio (BLTE) EBITDA (2022 - 2026) Analysis & Trends
Belite Bio's EBITDA history runs 5 years deep, the most recent figure standing at -$32.7 million for Q1 2026.
- In Q1 2026, EBITDA rose 100.0% year-over-year to -$32.7 million; the TTM figure through Mar 2026 stood at -$17.6 billion (up 99.89% YoY), while the FY2025 annual figure was -$84.2 million, down 110.54% from the prior year.
- EBITDA for Q1 2026 stood at -$32.7 million, down from -$28077.0 in the prior quarter.
- The five-year high for EBITDA was -$23018.0 in Q3 2025, with the low at -$15517.0 billion in Q1 2025.
- The 5-year median for EBITDA is -$7.6 billion (2023), against an average of -$1829.3 billion.
- The sharpest annual moves came in 2025 and 2026: EBITDA slumped 186223.25% in 2025, then surged 100.0% in 2026.
- Belite Bio's EBITDA stood at -$6721.0 billion in 2022, then dropped by 3.48% to -$6955.0 billion in 2023, then soared by 99.84% to -$11.5 billion in 2024, then surged by 100.0% to -$28077.0 in 2025, then sank by 116308.45% to -$32.7 million in 2026.
- Business Quant data shows BLTE's EBITDA at -$32.7 million in Q1 2026, -$28077.0 in Q4 2025, and -$23018.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | -32.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.68 Mn |
| Dec 31, 2025 | -28,077.00 |
| Sep 30, 2025 | -23,018.00 |
| Jun 30, 2025 | -17.60 Bn |
| Mar 31, 2025 | -15,517.00 Bn |
| Dec 31, 2024 | -11.46 Bn |
| Sep 30, 2024 | -9.74 Bn |
| Jun 30, 2024 | -10.47 Bn |
| Mar 31, 2024 | -8.33 Bn |
| Dec 31, 2023 | -6,955.00 Bn |
| Sep 30, 2023 | -10.96 Mn |
| Jun 30, 2023 | -6.87 Bn |
| Mar 31, 2023 | -6.88 Bn |
| Dec 31, 2022 | -6,721.00 Bn |
| Sep 30, 2022 | -2.54 Bn |
| Jun 30, 2022 | -2.51 Bn |